Schedule 13G ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Security class unavailable · CUSIP: 75629V104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
24,272,798
Percent of class
8.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000932471-24-000601
Form type
SC 13G/A
Filer
RECURSION PHARMACEUTICALS, INC.
CIK
CIK 1601830
Filed
Nov 04, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub